Experimental stem cell treatment tested during heart bypass surgery
NCT ID NCT07192211
Summary
This study is testing whether a stem cell treatment called ADR-002K can help people with heart failure who are having coronary artery bypass surgery. The treatment involves applying stem cells directly to the heart during the surgery. Researchers will follow 50 patients for two years to see if it reduces serious heart problems and improves heart strength and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC HEART DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.